Security Snapshot

PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) Institutional Ownership

CUSIP: 69366J200

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

381

Shares (Excl. Options)

100,539,987

Price

$81.57

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+5,526,133
Value change
+$470,023,369
Number of holders
381
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
81,782,297
SEC-reported price per share
$73.70
Insider filing price
$73.70
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share is tracked under CUSIP 69366J200.
  • 381 institutions reported positions in Q2 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 352 to 381 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $6,507,518,709 to $8,199,333,058.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 381 institutions filings for Q2 2026.

Open SEC evidence

Security key

69366J200

Latest holder period

Q2 2026

13F holders

381

13D/G owners

9

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
PTCT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% +85% $892,256,965 +$421,991,884 11,904,696 +90% BlackRock, Inc. 30 Nov 2025
JANUS HENDERSON GROUP PLC 8.7% +45% $494,116,913 +$160,878,918 7,193,433 +48% JANUS HENDERSON GROUP PLC 31 Mar 2026
ARMISTICE CAPITAL, LLC 6.9% -18% $269,133,425 -$46,705,135 5,434,843 -15% Armistice Capital, LLC 31 Mar 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 5.9% $331,883,645 4,871,329 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $291,899,442 4,284,448 Vanguard Capital Management 31 Mar 2026
STATE STREET CORP 5.2% $326,100,949 4,206,126 STATE STREET CORPORATION 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP 4.8% -23% $299,837,971 -$71,307,675 3,867,380 -19% Wellington Management Group LLP 31 Dec 2025
Camber Capital Management LP 4.2% $158,464,000 3,200,000 Camber Capital Management LP 31 Dec 2024
TORONTO DOMINION BANK 3.7% -30% $207,852,162 -$76,401,826 3,025,945 -27% The Toronto-Dominion Bank 31 Mar 2026

As of 30 Jun 2026, 381 institutional investors reported holding 100,539,987 shares of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT). This represents 123% of the company’s total 81,782,297 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
89%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 17% 13,964,554 +7.8% 0.02% $1,139,088,671
RTW INVESTMENTS, LP 9.5% 7,746,415 0% 5.4% $631,875,072
Jupiter Topco LLC 8.8% 7,236,402 0% 0.24% $590,181,512
VANGUARD PORTFOLIO MANAGEMENT LLC 6% 4,928,111 +2.6% 0.02% $401,986,014
STATE STREET CORP 5.6% 4,598,952 +5.8% 0.01% $375,136,515
WELLINGTON MANAGEMENT GROUP LLP 5% 4,128,273 +4.7% 0.06% $336,743,228
VANGUARD CAPITAL MANAGEMENT LLC 4.6% 3,739,127 +1.7% 0.01% $305,000,589
GEODE CAPITAL MANAGEMENT, LLC 2.7% 2,207,376 -0.12% 0.01% $180,089,116
TORONTO DOMINION BANK 2.6% 2,165,846 -28% 0.29% $176,668,031
WESTFIELD CAPITAL MANAGEMENT CO LP 2.4% 1,956,156 0.52% $159,563,645
Hood River Capital Management LLC 2.1% 1,738,613 +4.4% 1% $141,818,662
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.1% 1,722,688 0.42% $140,519,660
D. E. Shaw & Co., Inc. 1.9% 1,548,919 -5.6% 0.08% $126,345,323
TANG CAPITAL MANAGEMENT LLC 1.8% 1,500,000 0% 5.6% $122,355,000
BANK OF AMERICA CORP /DE/ 1.8% 1,452,277 -23% 0.01% $118,462,234
Driehaus Capital Management LLC 1.8% 1,440,107 +42% 0.68% $117,469,528
FMR LLC 1.7% 1,398,261 -8.5% 0% $114,056,206
Jefferies Financial Group Inc. 1.7% 1,357,042 +0.19% 1% $110,693,916
FULLER & THALER ASSET MANAGEMENT, INC. 1.4% 1,156,819 0.26% $94,361,749
Pictet Asset Management Holding SA 1.4% 1,147,844 -3% 0.09% $93,629,635
PRICE T ROWE ASSOCIATES INC /MD/ 1.4% 1,114,516 +135% 0.01% $90,912,000
MORGAN STANLEY 1.3% 1,103,675 +64% 0% $90,026,886
ARMISTICE CAPITAL, LLC 1.3% 1,071,395 -48% 2.4% $87,393,690
Blue Sparrow, LLC /DE 1.3% 1,050,700 +451% 0.83% $85,705,599
FRANKLIN RESOURCES INC 1.3% 1,027,327 -8.4% 0.02% $83,799,082

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 100,539,987 $8,199,333,058 +$470,023,369 $81.57 381
2026 Q1 95,527,235 $6,507,518,709 +$134,655,067 $68.13 352
2025 Q4 92,686,841 $7,040,774,871 +$724,074,706 $75.96 350
2025 Q3 82,678,571 $5,073,764,701 +$181,615,186 $61.37 290
2025 Q2 79,911,059 $3,903,121,530 +$46,553,598 $48.84 281
2025 Q1 78,779,105 $4,025,030,193 +$67,568,904 $50.96 260
2024 Q4 77,719,633 $3,508,291,455 -$16,690,343 $45.14 237
2024 Q3 78,808,939 $2,925,502,301 -$38,880,960 $37.10 199
2024 Q2 79,829,985 $2,441,610,603 -$156,636,791 $30.58 196
2024 Q1 85,061,593 $2,474,579,740 +$22,339,643 $29.09 179
2023 Q4 84,601,340 $2,331,624,240 +$83,990,908 $27.56 169
2023 Q3 81,614,706 $1,828,981,040 -$51,055,249 $22.41 175
2023 Q2 81,025,132 $3,295,908,701 +$98,098,293 $40.67 201
2023 Q1 78,433,463 $3,798,260,033 +$90,684,481 $48.44 198
2022 Q4 76,981,862 $2,938,237,687 +$13,606,355 $38.17 196
2022 Q3 76,313,271 $3,830,944,634 +$86,495,993 $50.20 199
2022 Q2 74,083,474 $2,967,960,851 +$15,896,836 $40.06 171
2022 Q1 73,730,204 $2,750,879,876 -$34,162,193 $37.31 170
2021 Q4 75,095,879 $2,991,389,896 +$33,191,074 $39.83 166
2021 Q3 74,270,018 $2,763,598,375 +$31,311,987 $37.21 174
2021 Q2 73,830,496 $3,120,577,918 +$3,824,478 $42.27 174
2021 Q1 73,197,638 $3,466,689,095 +$45,849,603 $47.35 196
2020 Q4 72,827,805 $4,447,644,286 +$100,239,157 $61.03 205
2020 Q3 71,012,920 $3,320,619,406 +$114,326,210 $46.75 189
2020 Q2 68,359,820 $3,451,278,985 +$259,126,213 $50.74 198
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .